Search

An experimental drug that has shown promise in protecting healthy tissue from collateral damage caused by radiation therapy for cancer also appears to enhance radiation’s capacity to kill tumors.

A chemical modification of RNA that can be influenced by diet appears to play a key role in polycystic kidney disease, an inherited disorder that is the fourth leading cause of kidney failure in the U.S.

UT Southwestern Simmons Cancer Center researchers have developed technology that is spawning a much better form of drug delivery for gene therapy and has achieved a 43 percent increase in the survival of mice with glioblastoma, one of the deadliest forms of human brain cancer.

Seven UT Southwestern Medical School students have been selected Dallas-Fort Worth Albert Schweitzer Fellows for projects addressing digital literacy, smoking cessation, health care navigation, and health care access.

Unvaccinated pregnant women are increasingly being hospitalized with COVID-19 during a nationwide surge of the Delta variant, according to research from UT Southwestern Medical Center.

A study by UT Southwestern neurology researchers found that Hispanic people have lower-quality outcomes than white people among ischemic stroke patients who receive endovascular thrombectomies. Racial disparities were not found between Black and white patients.

Leading attorney Jeffrey A. Chapman assumes the role of Chair of the President’s Advisory Board (PAB) at UT Southwestern Medical Center.

Patients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with their results.

UT Southwestern Medical Center is expanding its neurological surgery program to Texas Health Presbyterian Hospital Dallas.

UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.